CAN.AX
Price:
$0.038
Market Cap:
$20.36M
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-05-05
Stock Exchange
ASX
Ticker
CAN.AX
According to Cann Group Limited’s latest financial reports and current stock price. The company's current ROE is -159.56%. This represents a change of 85.44% compared to the average of -86.04% of the last 4 quarters.
The mean historical ROE of Cann Group Limited over the last ten years is -127.94%. The current -159.56% ROE has changed 24.72% with respect to the historical average. Over the past ten years (40 quarters), CAN.AX's ROE was at its highest in in the January 2016 quarter at 0%. The ROE was at its lowest in in the June 2024 quarter at -265.10%.
Average
-127.94%
Median
-29.45%
Minimum
-644.19%
Maximum
-5.50%
Discovering the peaks and valleys of Cann Group Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 545.56%
Maximum Annual ROE = -5.50%
Minimum Annual Increase = -86.57%
Minimum Annual ROE = -644.19%
Year | ROE | Change |
---|---|---|
2024 | -368.09% | 545.56% |
2023 | -57.02% | 82.90% |
2022 | -31.17% | 14.09% |
2021 | -27.32% | -1.47% |
2020 | -27.73% | 96.19% |
2019 | -14.14% | 156.85% |
2018 | -5.50% | -68.83% |
2017 | -17.66% | -79.60% |
2016 | -86.54% | -86.57% |
The current ROE of Cann Group Limited (CAN.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-152.09%
5-year avg
-102.27%
10-year avg
-127.94%
Cann Group Limited’s ROE is greater than Creso Pharma Limited (-130.99%), greater than Althea Group Holdings Limited (-414.04%), greater than Elixinol Wellness Limited (-98.83%), less than MGC Pharmaceuticals Limited (562.83%), less than Zelira Therapeutics Limited (1.07%),
Company | ROE | Market cap |
---|---|---|
-130.99% | $23.11M | |
-414.04% | $13.78M | |
-98.83% | $8.83M | |
562.83% | $18.42M | |
1.07% | $7.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cann Group Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cann Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Cann Group Limited's ROE?
How is the ROE calculated for Cann Group Limited (CAN.AX)?
What is the highest ROE for Cann Group Limited (CAN.AX)?
What is the 3-year average ROE for Cann Group Limited (CAN.AX)?
What is the 5-year average ROE for Cann Group Limited (CAN.AX)?
How does the current ROE for Cann Group Limited (CAN.AX) compare to its historical average?